Ginger Supplementation in Nonalcoholic Fatty Liver Disease: A Randomized, Double-Blind, Placebo-Controlled Pilot Study.

ABSTRACT:

Background

Nonalcoholic fatty liver disease (NAFLD) is one of the most common chronic liver diseases worldwide. The pathogenesis of this disease is closely associated with obesity and insulin resistance. Ginger can have hypolipidemic and antioxidant effects, and act as an insulinsensitizer.

Objectives

The aim of this study was to evaluate the effects of ginger supplementation in NAFLD management.

Patients and methods

In a randomized, double-blind, placebo-controlled clinical trial, 44 patients with NAFLD were assigned to take either two grams per day of a ginger supplement or the identical placebo, for 12 weeks. In both groups, patients were advised to follow a modified diet and physical activity program. The metabolic parameters and indicators of liver damage were me

SUBMITTER: Rahimlou M 

PROVIDER: S-EPMC4834197 | biostudies-literature | 2016 Jan

REPOSITORIES: biostudies-literature